Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MESA LABORATORIES INC /CO/MLAB · Entity 5221 | CFO | June 18, 2026 | June 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MESA LABORATORIES INC /CO/
Report date June 18, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,785 |
Ending reported balance
After 2026-06-22 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-06-18 · Exercise / conversion · Acquired 1,036 · Balance 17,574 Row 2 · 2026-06-18 · Exercise / conversion · Acquired 2,756 · Balance 20,330 Row 3 · 2026-06-18 · Grant · Acquired 2,282 · Balance 22,612 F5: Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY24-FY26 performance share unit program Row 4 · 2026-06-22 · Sale · Disposed 2,827 · Balance 19,785 F6: Shares sold to cover taxes related to the vesting of RSUs and PSUs on June 18, 2026. Transaction was executed under a 10b5-1 plan. |
| Restricted Stock Units - 6SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-06-18 · Exercise / conversion · Disposed 1,036 · Balance 0 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2: RSUs that vested June 21, 2024 and each of the next two anniversary dates F3: Not Applicable |
| Restricted Stock Units - 7SEC Table II · derivative / convertible security | Direct | 2,755 |
Reported balance
After 2026-06-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-06-18 · Exercise / conversion · Disposed 2,756 · Balance 2,755 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F4: RSUs that vest 1/3 on June 15, 2026 and each of the next 2 anniversary dates F3: Not Applicable |
| Common StockSEC Table I · non-derivative | IndirectCustodian | 50 |
Reported balance
Holding disclosure · report date 2026-06-18 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 50 F7: Consists of 50 shares held by children of which Mr. Sakys is custodian |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: RSUs that vested June 21, 2024 and each of the next two anniversary dates
F3: Not Applicable
F4: RSUs that vest 1/3 on June 15, 2026 and each of the next 2 anniversary dates
F5: Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY24-FY26 performance share unit program
F6: Shares sold to cover taxes related to the vesting of RSUs and PSUs on June 18, 2026. Transaction was executed under a 10b5-1 plan.
F7: Consists of 50 shares held by children of which Mr. Sakys is custodian
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 11, 2021 Filed Nov 12, 2021 16:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,000 | $0.00 Strike: $97.78 | $0.00 |
DisclosureSEC source: 0001228924-21-000078 · primary_doc.xml · derivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,029 Underlying: Common Stock · 1,000 shares Expires 2022-04-01 F1 · derivative.exercise_date: 1/5 exercisable on each anniversary date of the 04-01-2016 grant date Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 16:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,000 | $317.12 | $317,120.00 |
DisclosureSEC source: 0001228924-21-000078 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,514 Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 16:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,000 | $97.78 | $97,780.00 |
DisclosureSEC source: 0001228924-21-000078 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2021 Filed Oct 25, 2021 13:54 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 2,000 | $0.00 Strike: $97.78 | $0.00 |
DisclosureSEC source: 0001228924-21-000074 · primary_doc.xml · derivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,029 Underlying: Common Stock · 2,000 shares Expires 2022-04-01 F1 · derivative.exercise_date: 1/5 exercisable on each anniversary date of the 04-01-2016 grant date Read SEC document |
| October 20, 2021 Filed Oct 25, 2021 13:54 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | SaleCommon Stock | 2,000 | $309.86 | $619,720.00 |
DisclosureSEC source: 0001228924-21-000074 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,514 F2 · shares: Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on March 1, 2021 Read SEC document |
| October 20, 2021 Filed Oct 25, 2021 13:54 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | Exercise / conversionCommon Stock | 2,000 | $97.78 | $195,560.00 |
DisclosureSEC source: 0001228924-21-000074 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 10, 2021 23:23 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,400 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-21-000072 · primary_doc.xml · derivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,029 Underlying: Common Stock · 1,400 shares Expires 2022-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/2014 grant date Read SEC document |
| September 10, 2021 Filed Sep 10, 2021 23:23 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,400 | $270.21 | $378,294.00 |
DisclosureSEC source: 0001228924-21-000072 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,514 F2 · shares: Sale reported on Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on March 1, 2021 Read SEC document |
| September 10, 2021 Filed Sep 10, 2021 23:23 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,400 | $89.70 | $125,580.00 |
DisclosureSEC source: 0001228924-21-000072 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 23:27 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon Qualified Stock Options · Derivative | 4,933 | $0.00 Strike: $268.85 | $0.00 |
DisclosureSEC source: 0001228924-21-000070 · primary_doc.xml · derivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,429 Underlying: Common Stock · 4,933 shares Expires 2027-09-01 F6 · derivative.exercise_date: NSOs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and 1/3 on June 15, 2024 Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 23:27 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 4 · Derivative | 1,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000070 · primary_doc.xml · derivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,303 Underlying: Common Stock · 1,303 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · shares: RSUs granted for navigation of the Company through Covid-19 F5 · derivative.exercise_date: RSUs that cliff vest on September 1, 2022 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 23:27 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 3 · Derivative | 1,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000070 · primary_doc.xml · derivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,537 Underlying: Common Stock · 1,537 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and 1/3 on June 15, 2024 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 17:49 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,000 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-21-000051 · primary_doc.xml · derivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,296 Underlying: Common Stock · 1,000 shares Expires 2022-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/2014 grant date Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 17:49 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,000 | $275.16 | $275,160.00 |
DisclosureSEC source: 0001228924-21-000051 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,514 F2 · shares: Sale reported on Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on March 1, 2021 Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 17:49 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,000 | $89.70 | $89,700.00 |
DisclosureSEC source: 0001228924-21-000051 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 16:02 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,000 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-21-000046 · primary_doc.xml · derivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,496 Underlying: Common Stock · 1,000 shares Expires 2022-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/2014 grant date Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 16:02 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,000 | $278.77 | $278,770.00 |
DisclosureSEC source: 0001228924-21-000046 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,514 F2 · shares: Sale reported on Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on March 1, 2021 Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 16:02 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,000 | $89.70 | $89,700.00 |
DisclosureSEC source: 0001228924-21-000046 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:11 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,000 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-21-000045 · primary_doc.xml · derivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,496 Underlying: Common Stock · 1,000 shares Expires 2022-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/2014 grant date Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:11 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | SaleCommon Stock | 1,000 | $267.04 | $267,040.00 |
DisclosureSEC source: 0001228924-21-000045 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,514 Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:11 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | Exercise / conversionCommon Stock | 1,000 | $89.70 | $89,700.00 |
DisclosureSEC source: 0001228924-21-000045 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 16:50 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 2,119 | $255.67 | $541,764.73 |
DisclosureSEC source: 0001228924-21-000041 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,514 F2 · shares: Shares sold to cover taxes associated with Performance Share Units Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 21:14 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 2 · Derivative | 681 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000036 · primary_doc.xml · derivative · entry 5 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 681 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs granted for 10% salary reduction for the twelve months ended May 31, 2021 and 60% of cash bonus target for Fiscal Year 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 21:14 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 405 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000036 · primary_doc.xml · derivative · entry 4 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 784 Underlying: Common Stock · 405 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/3 on June 15, 2021 and each of the next two anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 21:14 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 479 | $263.30 | $126,120.70 |
DisclosureSEC source: 0001228924-21-000036 · primary_doc.xml · nonDerivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,957 F5 · shares: Represents shares of common stock received by Mesa Labs for tax withholding purposes in connection with the net-settlement of the issuance of shares of common stock in respect to the vested RSUs. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 21:14 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 681 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000036 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 21:14 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 405 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000036 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 16:50 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 4,676 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000041 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,633 F1 · shares: Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY19-FY21 performance share unit program Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 13:50 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 2,000 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-21-000011 · primary_doc.xml · derivative · entry 5 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,496 Underlying: Common Stock · 2,000 shares Expires 2023-04-01 F2 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the April 1, 2015 grant date Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 13:50 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 500 | $0.00 Strike: $48.72 | $0.00 |
DisclosureSEC source: 0001228924-21-000011 · primary_doc.xml · derivative · entry 4 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,496 Underlying: Common Stock · 500 shares Expires 2022-10-29 F1 · derivative.exercise_date: 1/4 exercisable on each anniversary date of the 10-29-12 grant date Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 13:50 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | SaleCommon Stock | 2,500 | $263.84 | $659,600.00 |
DisclosureSEC source: 0001228924-21-000011 · primary_doc.xml · nonDerivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,350 Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 13:50 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | Exercise / conversionCommon Stock | 2,000 | $70.56 | $141,120.00 |
DisclosureSEC source: 0001228924-21-000011 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 13:50 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | Exercise / conversionCommon Stock | 500 | $48.72 | $24,360.00 |
DisclosureSEC source: 0001228924-21-000011 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2021 Filed Jan 11, 2021 19:26 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon-Qualified Stock Options · Derivative | 1,000 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-21-000003 · primary_doc.xml · derivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,996 Underlying: Common Stock · 1,000 shares Expires 2022-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 4-1-2014 grant date Read SEC document |
| January 08, 2021 Filed Jan 11, 2021 19:26 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,000 | $89.70 | $89,700.00 |
DisclosureSEC source: 0001228924-21-000003 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Transaction reported on Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23, 2020 Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 16:40 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon-Qualified Stock Option · Derivative | 16 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-21-000002 · primary_doc.xml · derivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,996 Underlying: Common Stock · 16 shares Expires 2022-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 4-1-2014 grant Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 16:40 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 16 | $290.00 | $4,640.00 |
DisclosureSEC source: 0001228924-21-000002 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,350 F2 · kind: Sale reported on Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23, 2020 Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 16:40 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 16 | $89.70 | $1,435.20 |
DisclosureSEC source: 0001228924-21-000002 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2020 Filed Nov 18, 2020 17:40 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 984 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-20-000039 · primary_doc.xml · derivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,012 Underlying: Common Stock · 984 shares Expires 2022-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 4-1-2014 grant date Read SEC document |
| November 17, 2020 Filed Nov 18, 2020 17:40 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 984 | $290.00 | $285,360.00 |
DisclosureSEC source: 0001228924-20-000039 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,350 F2 · kind: Sale reported on Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23, 2020 Read SEC document |
| November 17, 2020 Filed Nov 18, 2020 17:40 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 984 | $89.70 | $88,264.80 |
DisclosureSEC source: 0001228924-20-000039 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 08, 2020 Filed Oct 9, 2020 22:29 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherIncentive Stock Option · Derivative | 942 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-20-000029 · primary_doc.xml · derivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,996 Underlying: Common Stock · 942 shares Expires 2022-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 4-1-2014 grant date Read SEC document |
| October 08, 2020 Filed Oct 9, 2020 22:29 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 942 | $276.90 | $260,839.80 |
DisclosureSEC source: 0001228924-20-000029 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,350 F2 · kind: Sale reported on Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23, 2020 Read SEC document |
| October 08, 2020 Filed Oct 9, 2020 22:29 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 942 | $89.70 | $84,497.40 |
DisclosureSEC source: 0001228924-20-000029 · primary_doc.xml · nonDerivative · entry 1 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 15:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 702 | $0.00 Strike: $48.72 | $0.00 |
DisclosureSEC source: 0001228924-20-000025 · primary_doc.xml · derivative · entry 7 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,938 Underlying: Common Stock · 1,000 shares Expires 2022-10-29 F1 · derivative.exercise_date: 1/4 exercisable on each anniversary date of the 10/29/2012 grant date Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 15:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000025 · primary_doc.xml · nonDerivative · entry 5 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,350 Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 15:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 702 | $251.42 | $176,496.84 |
DisclosureSEC source: 0001228924-20-000025 · primary_doc.xml · nonDerivative · entry 4 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,400 F2 · kind: Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23,2020 Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 15:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 702 | $48.72 | $34,201.44 |
DisclosureSEC source: 0001228924-20-000025 · primary_doc.xml · nonDerivative · entry 3 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 4, 2020 15:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 298 | $0.00 Strike: $48.72 | $0.00 |
DisclosureSEC source: 0001228924-20-000025 · primary_doc.xml · derivative · entry 6 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,640 Underlying: Common Stock · 298 shares Expires 2022-10-29 F1 · derivative.exercise_date: 1/4 exercisable on each anniversary date of the 10/29/2012 grant date Read SEC document |
| September 01, 2020 Filed Sep 4, 2020 15:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 298 | $250.00 | $74,500.00 |
DisclosureSEC source: 0001228924-20-000025 · primary_doc.xml · nonDerivative · entry 2 Sakys John · CIK 0001197710 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,400 F2 · kind: Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23,2020 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.